AntibioticDB

Taniborbactam, VNRX-5133

Beta-lactamase inhibitor

Venatorx Pharmaceuticals, USA

2019

Highest development stage: Preclinical
Gram-positive activity
Mechanism of Action/Target pathogen: Enterobacterales and Pseudomonas aeruginosa
GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10774
Source: https://aac.asm.org/content/64/3/e01963-19
Compound/Drug Structure: https://pubchem.ncbi.nlm.nih.gov/compound/76902493